Bodhi Tree Biotechnology (BDTB) EBIT (2024 - 2025)
Bodhi Tree Biotechnology (BDTB) reported EBIT of -$52949.0 for Q4 2025, up 18.26% year-over-year from -$44773.5 in Q4 2024, and down 395.45% quarter-over-quarter from -$10687.0 in Q3 2025.
Bodhi Tree Biotechnology (BDTB) EBIT (2024 - 2025) Analysis & Trends
Bodhi Tree Biotechnology (BDTB) has 2 years of EBIT data on file, last reported at -$52949.0 in Q4 2025.
- EBIT for Q4 2025 came in at -$52949.0, up 18.26% year-over-year; the trailing twelve-month figure through Dec 2025 was -$135790.0 (changed N/A YoY), and the FY2025 annual result was -$147618.0, down 138.27% from the prior year.
- EBIT declined to -$52949.0 in Q4 2025 per BDTB's latest filing, from -$10687.0 in the prior quarter.
- Over five years, EBIT peaked at -$10687.0 in Q3 2025 and troughed at -$64777.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -52,949.00 |
| Sep 30, 2025 | -10,687.00 |
| Jun 30, 2025 | -19,975.00 |
| Mar 31, 2025 | -52,179.00 |
| Dec 31, 2024 | -64,777.00 |